Good morning. The Supreme Court is allowing the Trump administration to cut $783 million in research grants tied to DEI work.

Gilead subsidiary Kite Pharma said that it has acquired Interius BioTherapeutics and its single-shot CAR-T program for $350 million.

These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...

Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...

A woman came into triage with her 6-week-old baby, terrified. She had little support at home and was worried about caring for ...

The Trump administration can slash $783 million of research funding in its push to cut federal diversity, equity and ...

On September 10, join this virtual event to hear industry-leading insights to improve operational efficiency and regulatory ...

A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a ...

The shooter, identified by authorities as Patrick Joseph White, appears to have been captured in security camera footage ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.

Epic Systems announced a bevy of new AI products at the annual meeting for its EHR customers this week, including an AI scribe and AI assistants aimed at clinicians, patients, and admin staff. My ...

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...